Delivery Order SPE2DB22D3009-SPE2DB25FAP34
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.41 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,147.97 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, which are prescription medications used for the treatment of alcohol and opioid dependence. The contract has a completion date of July 25, 2022 and was awarded on July 22, 2022. AmerisourceBergen holds a significant...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of VIVITROL 380 MG VIAL-DILUENTS to support the U.S. government's medical and healthcare needs. The $12,599.09 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 30, 2024. The contract does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,197.25 firm fixed-price delivery order contract is for the provision of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,567.40 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for the supply of Vivitrol 380 mg vials and diluents, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of March 17, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,003.51 firm fixed-price delivery order is for the provision of 380 mg VIVITROL vials and diluents. The contract has an ultimate completion date of April 2, 2025 and does not utilize any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,273.59 firm-fixed-price delivery order contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of January 15, 2025. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,485.86 firm fixed-price delivery order covers the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid and alcohol dependence. The contract has a performance period ending on May 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...